Grünenthal GmbH

About

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. Our ambition is to deliver new products to patients in diseases with high unmet medical need.

Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in R&D above the industrial average, Grünenthal is strongly committed to innovation.

Grünenthal is an independent, family-owned company headquartered in Aachen, Germany. Grünenthal is present in approx. 30 countries with affiliates in Europe, Latin America and the US. Its products are sold in more than 100 countries and approx. 5,200 employees are working for the Grünenthal Group worldwide.

  1. Societal Impact of Pain (SIP)
  2. SIP Platform
  3. Endorsement Detail
  • Register for the SIP Newsletter

    Stay informed about the most important events and news about the Societal Impact of Pain platform.

    subscribe now

Essential

Essential cookies are essential for the operation of the website and can therefore not be deactivated.

Cookie information

Statistics

Statistics cookies allow the collection of anonymous information about how you use our website. They help us to improve your user experience and our content.

Cookie information

External media

External media cookies allow media content to be loaded from external sources. They can also be activated when you visit the website if you encounter blocked media content.

Cookie information